Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Market Leaders Strategize to Meet Escalating Demand in Research Antibodies & Reagents Industry, More than $21.28 Billion Revenue to be Generated by 2029 - Arizton

This image opens in the lightbox

News provided by

Arizton Advisory & Intelligence

26 Mar, 2024, 16:50 GMT

Share this article

Share toX

Share this article

Share toX

CHICAGO, March 26, 2024 /PRNewswire/ -- According to Arizton's latest research report, the global research antibodies & reagents market is growing at a CAGR of 8.03% 2023-2029. 

To Know More, Click: https://www.arizton.com/market-reports/research-antibodies-and-reagents-market

Continue Reading
This image opens in the lightbox
Research Antibodies & Reagents Market Research Report by Arizton

Browse In-depth TOC on the Research Antibodies & Reagents Market 

447 – Pages 
187 - Tables 
146 - Figures  

Research Antibodies & Reagents Market Report Scope

Report Attributes 

Details 

Market Size (2029) 

USD 21.28 Billion

Market Size (2023) 

USD 13.39 Billion

CAGR (2023-2029) 

8.03 %

Historic Year 

2020-2022

Base Year 

2023

Forecast Year 

2024-2029 

Market Segmentation 

Product Type, Technology, Application, End-user, and Geography

Geographic Analysis 

North America, Europe, APAC, Latin America, and Middle East & Africa 

Market Dynamics  

•  Increase in Research Academies and Industry Collaborations

•  Growing R&D and Research Funding for Antibodies Development

•  Rise in Proteomics and Genomics Research

The research antibodies and reagents market is vital to the global life sciences and biotechnology sectors. It serves as an essential tool for researchers and scientists across disciplines. The market is poised for growth with ongoing technological advances and the increasing demand for personalized medicine and biopharmaceutical development. However, it must address quality control and regulatory challenges to ensure continued success. As the field evolves, stakeholders should adapt to changing dynamics to remain competitive in this growing industry. Antibodies play a crucial role in diagnostic applications, including immunoassays for infectious diseases, cancer biomarkers, and companion diagnostics for personalized medicine. The market is expected to continue growing in the future. There is a growing demand for customized and personalized research antibodies and reagents to meet specific research needs. Advances in antibody engineering and reagent synthesis techniques, such as recombinant antibody technology and phage display, will improve product quality.

Rise in Proteomics and Genomics Research Creating Boom in the Market

The remarkable growth in proteomics and genomics research would not have been possible without specialized tools and reagents. Research antibodies are indispensable in these fields. They are designed to recognize specific proteins or DNA sequences, enabling scientists to pinpoint and study these molecules. These antibodies have a multitude of applications, from Western blotting and immunohistochemistry to ChIP-Seq and ELISAs, serving as critical components in a wide range of laboratory techniques.

The fields of proteomics and genomics have witnessed an extraordinary surge in research activities and applications over the last few decades. These branches of life sciences focus on the comprehensive study of proteins and genes, respectively, and play a pivotal role in unraveling the complexities of life and disease. Rapid technological advances have made a deeper understanding of the human genome and proteome increasingly accessible. This surge in research, driven by the promise of groundbreaking discoveries and clinical applications, is proving to be a driving force behind the thriving research antibodies and reagents market.

ELISA Technology to Hold the Largest Share Whereas Western Blotting to Witness the Fastest Growth Rate

In 2023, the ELISA segment accounted for a share of 25.77% of the global research antibodies & reagents market.

Enzyme-Linked Immunosorbent Assay (ELISA) technology is a cornerstone of the research antibodies and reagents market, it does face certain challenges. ELISA's sensitivity and specificity can vary; continuous improvement is necessary to enhance its accuracy. ELISA assays can be costly, necessitating the development of cost-effective alternatives. Traditional ELISA assays often involve manual steps, making automation an area for improvement.

The ability to simultaneously measure multiple analytes in a single sample is an ongoing development area. In response to these challenges, there have been innovations such as the development of microfluidic ELISA platforms, improved reagents, and digital ELISA, which enhances sensitivity and quantification.

Western blotting technology is vital in the research antibodies and reagents market. Western blotting is a fundamental method for validating the specificity and sensitivity of antibodies. Researchers use Western blots to confirm that antibodies recognize the target proteins accurately. It enables the detection and quantification of proteins in complex biological samples, such as cell lysates, tissues, and serum. This is crucial for various research applications, including biomarker discovery, disease mechanisms, and drug development.

The APAC Research Antibodies & Reagents Market to Hit $4.9 Billion by 2029

The research antibodies and reagents market in APAC is becoming increasingly competitive. Companies need to focus on product differentiation, quality assurance, and establishing strong partnerships with local research institutions to thrive. Adherence to regulatory standards is crucial in the life sciences industry. Companies operating in the APAC market should be well-versed with local and international regulations to ensure the quality and compliance of their products.

Enhancing awareness and providing educational resources about the benefits and applications of research antibodies and reagents is essential. Collaborations with academic institutions for training programs and workshops can contribute to market growth. Tailoring products to meet the diverse APAC market's specific research needs and preferences is essential. Companies should understand local research trends and collaborate with researchers to develop customized solutions.

Research Antibodies & Reagents Market Report Encompasses Crucial Data, including:   

Market size and growth forecast for 10 years from 2020-2029           

CAGR (Compound Annual Growth Rate) during the forecast period: This metric provides insights into the annual growth rate of the research antibodies & reagents market over the specified time frame.             

Detailed information on growth drivers: The report offers in-depth information on the factors that will propel the research antibodies & reagents market growth from 2023 to 2029. This includes an analysis of various market influences.             

Precise estimation of market size: Accurate assessments of the research antibodies & reagents market size and its contribution, focusing on key market segments.             

Predictions about upcoming trends and changes in consumer behavior: The report offers insights into anticipated trends and shifts in consumer behavior that are likely to impact the research antibodies & reagents market, helping businesses prepare for future market dynamics.             

Geographical market growth: The report covers the development of the research antibodies & reagents market across different regions, including North America, Europe, APAC, Latin America, the Middle East, and Africa. This provides a comprehensive understanding of the market's global landscape.             

Competitive landscape analysis: A thorough examination of the market's competitive landscape is presented, including detailed information about companies operating in the research antibodies & reagents market. This includes an overview of key players, their market share, strategies, and key developments.             

Analysis of growth challenges: The report includes a comprehensive analysis of factors that may pose challenges to the growth of companies in the research antibodies & reagents market, providing a well-rounded view of the market dynamics.      

Buy this Research @ https://www.arizton.com/market-reports/research-antibodies-and-reagents-market

Post-Purchase Benefit                           

  • 1hr of free analyst discussion                          
  • 10% off on customization 

Key Company Profiles

  • Bio-Rad Laboratories
  • Bio-Techne
  • Danaher
  • F.Hoffmann La-Roche
  • Merck KGaA
  • Thermo Fisher Scientific
  • Abcepta
  • Abclonal
  • Abnova
  • Atlas Antibodies
  • Aviva Systems Biology
  • Cell Signaling Technology
  • Cantata Bio
  • Fujirebio
  • GeneTex
  • GenScript
  • ICL
  • Jackson ImmunoResearch
  • MBL International
  • Omega Bio-tek
  • Proteintech Group
  • RayBiotech Life
  • ROCKLAND IMMUNOCHEMICALS
  • Santa Cruz Biotechnology
  • SOL Group
  • SouthernBiotech

Market Segmentation

Product Type

  • Reagents
    • By Product Type
      • Media & Sera
      • Stains & Dyes
      • Buffers
      • Other
    • Antibody
      • By Product
        • Primary
        • Secondary
      • By Form
        • Monoclonal
        • Polyclonal
      • By Source
        • Rabbit
        • Mouse
        • Rat
        • Other
      • By Research Area
        • Oncology
        • Infectious Diseases
        • Immunology
        • Neurobiology
        • Stem Cell
        • Other

Technology

  • ELISA
  • Flow Cytometry
  • Western Blotting
  • Immunofluorescence
  • Immunohistochemistry
  • Immunoprecipitation
  • Other

Application

  • Proteomics
  • Drug Development
  • Genomics

End-user

  • Academic & Research Institutes and Research Labs
  • Pharma & Biotech Companies
  • CROs & CDMOs

Geography

  • North America
    • The US
    • Canada
  • Europe
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia
    • The UAE

Key Questions Answered in the Report: 

How big is the research antibodies & reagents market?

What is the growth rate of the global research antibodies & reagents market?

Which region dominates the global research antibodies & reagents market share?

What are the significant trends in the research antibodies & reagents industry?

Who are the key players in the global research antibodies & reagents market?

Get the Detailed TOC @ https://www.arizton.com/market-reports/research-antibodies-and-reagents-market

Check Out Some of the Top-Selling Research Reports:           

Rapid Diagnostics Market - Global Outlook and Forecast 2020-2025

Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028

Oncology Molecular Diagnostics Market – Global Outlook & Forecast 2023-2028

Digital Biomarkers Market - Global Outlook & Forecast 2024-2029

Why Arizton?                    

100% Customer Satisfaction                    

24x7 availability – we are always there when you need us                    

200+ Fortune 500 Companies trust Arizton's report                    

80% of our reports are exclusive and first in the industry                    

100% more data and analysis                    

1500+ reports published till date                     

About Us:                                                         

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                       

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                        

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                              

Contact Us                                                      

Call: +1-312-235-2040           
          +1 302 469 0707      
Mail: enquiry@arizton.com                     
Contact Us: https://www.arizton.com/contact-us                                                     
Blog: https://www.arizton.com/blog                                                     
Website: https://www.arizton.com/      

Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg 
Photo: https://mma.prnewswire.com/media/2371931/Research_Antibodies_Reagents_Market.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.